Spatial Analysis of the Tumor Microenvironment and Gene Expression in LSD1-expressing Triple-negative Breast Cancer (TNBC)

被引：0
|
作者：
Iqbal, Jabed [1 ]
Yeong, Joe [2 ]
Lee, Dong Yeul [3 ]
Hong, Jing Han [4 ]
机构：
[1] Singapore Gen Hosp, Singapore, Singapore
[2] ASTAR, Singapore Immunol Network, Singapore, Singapore
[3] Nanyang Technol Univ, Singapore, Singapore
[4] Duke Nus Med Sch Singapore, Singapore, Singapore
来源：
LABORATORY INVESTIGATION | 2024年 / 104卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
148
引用
收藏
页码：S177 / S179
页数：3
相关论文
共 50 条
  • [21] Tumor microenvironment key to halting metastases in triple-negative breast cancer
    Milburn, Joanna
    BREAST CANCER MANAGEMENT, 2012, 1 (04) : 261 - 262
  • [22] Activity of ixabepilone and PARP inhibitors in triple-negative breast cancer (TNBC) based on gene expression.
    Horak, C. E.
    Alexe, G.
    Baselga, J.
    Vahdat, L. T.
    Valero, V.
    Xing, G.
    Mukhopadhyay, P.
    Opatt, D. M.
    Sparano, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [23] Triple-negative breast cancer: Heterogeneity, tumor microenvironment and targeted therapy
    Deng, Xiyun
    Zheng, Chanjuan
    Tang, Faqing
    Rosol, Thomas J. J.
    Shao, Zhi-Ming
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [24] Genetic Heterogeneity, Tumor Microenvironment and Immunotherapy in Triple-Negative Breast Cancer
    Kudelova, Eva
    Smolar, Marek
    Holubekova, Veronika
    Hornakova, Andrea
    Dvorska, Dana
    Lucansky, Vincent
    Koklesova, Lenka
    Kudela, Erik
    Kubatka, Peter
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (23)
  • [25] Deconvolution of the triple-negative breast cancer microenvironment
    Saleh, Sadiq
    Gruosso, Tina
    Gigoux, Mathieu
    Bertos, Nicholas
    Omeroglu, Atilla
    Zuo, Dongmei
    Meterissian, Sarkis
    Hallett, Michael
    Park, Morag
    CANCER RESEARCH, 2016, 76
  • [26] Granzyme B Expression in the Tumor Microenvironment as a Prognostic Biomarker for Patients with Triple-Negative Breast Cancer
    Mizoguchi, Kimihisa
    Kawaji, Hitomi
    Kai, Masaya
    Morisaki, Takafumi
    Hayashi, Saori
    Takao, Yuka
    Yamada, Mai
    Shimazaki, Akiko
    Osako, Tomofumi
    Arima, Nobuyuki
    Okido, Masayuki
    Oda, Yoshinao
    Nakamura, Masafumi
    Kubo, Makoto
    CANCERS, 2023, 15 (18)
  • [27] Mutational analysis of triple-negative breast cancer (TNBC): CALGB 40603 (Alliance)
    Hoadley, Katherine A.
    Powell, Bradford C.
    Kanavy, Dona
    Marron, David
    Mose, Lisle E.
    Hyslop, Terry
    Berry, Donald A.
    Hahn, Olwen
    Tolaney, Sara M.
    Sikov, William M.
    Perou, Charles M.
    Carey, Lisa A.
    CANCER RESEARCH, 2020, 80 (04)
  • [28] Subtyping of triple-negative breast cancer (TNBC): A cohort study
    Thomssen, Christoph
    Hartung, Caroline
    Porsch, Martin
    Stuckrath, Kathrin
    Buchmann, Jorg
    Kantelhardt, Eva J.
    Vetter, Martina
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [29] Involvement of proinflammatory chemokines in triple-negative breast cancer (TNBC)
    Ignacio, Rosa Mistica C.
    Gibbs, Carla
    Lee, Eun-Sook
    Son, Deok-Soo
    CANCER RESEARCH, 2016, 76
  • [30] Updates on Targeted Therapy for Triple-Negative Breast Cancer (TNBC)
    Noor Z.S.
    Master A.
    Current Breast Cancer Reports, 2018, 10 (4) : 282 - 288
12345